FDA Drug Application (201922) for XIMINO by SUN PHARM INDS LTD

Back to FDA Applications sponsored by SUN PHARM INDS LTD

Application Number201922
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
DosageEQ 45MG BASE
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameXIMINO
Active IngredientMINOCYCLINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient MINOCYCLINE HYDROCHLORIDE6


Back to FDA Applications sponsored by SUN PHARM INDS LTD